Publication | Open Access

Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myeloma

Hematological MalignancyTumor BiologyMalignant Blood DisorderImmunologyChimeric MoleculesImmune Checkpoint InhibitorMultiple MyelomaPre-clinical ModelsImmunotherapyMedicineCell BiologyCancer Research